---
schema_version: "secwatch.filing_event.v1"
accession: "0001539497-24-000590"
form_type: "8-K"
ticker: null
cik: "0001358403"
company_name: "BELLICUM PHARMACEUTICALS, INC"
filed_at: "2024-02-23T23:59:59+00:00"
generated_at: "2026-06-05T16:51:03.840590+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bellicum advances dissolution: all directors resign, Dave Maggio named CEO

## Summary
- All five directors resigned effective Feb 23, 2024; Richard Fair remains sole director.
- CEO Richard Fair resigned; Dave Maggio appointed CEO effective same day.
- Consulting agreement with Fair extended to June 30, 2024.
- Stockholders approved dissolution plan on Feb 20, 2024; company winding down.
- Resignations not related to any disagreement with the company.

## SEC filing metadata
- accession: 0001539497-24-000590
- form_type: 8-K
- cik: 0001358403
- company_name: BELLICUM PHARMACEUTICALS, INC
- filed_at: 2024-02-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/n3936_x24-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001539497-24-000590
- JSON: https://secwatch.observer/filing/0001539497-24-000590.json
- Plain text: https://secwatch.observer/filing/0001539497-24-000590.txt

## Key facts
- Executive change
  Jon P. Stonehouse resigned as Director at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director
  source text: · Jon P. Stonehouse ( Audit Committee and Compensation Committee )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Charity D. Scripture resigned as Chief Development Officer at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Chief Development Officer
  source text: Charity D. Scripture resigned as Chief Development Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  James M. Daly resigned as Director at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director
  source text: each of the Company’s directors listed below submitted their resignation from the Board and the committees thereof opposite their name below, effective as of February 23, 2024. · Mr. James M. Daly ( Compensation Committee, Nominating Committee and Finance Committee )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Richard A. Fair resigned as President and Chief Executive Officer at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: Mr. Richard A. Fair resigned as President and Chief Executive Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Reid M. Huber resigned as Director at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director
  source text: · Reid M. Huber, Ph.D. ( Audit Committee, Nominating Committee, Science Committee and Finance Committee )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Dave Maggio was appointed as Chief Executive Officer at BELLICUM PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: the Board appointed Dave Maggio to the position of Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Judith Klimovsky resigned as Director at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director
  source text: · Judith Klimovsky M.D. ( Nominating Committee, Science Committee and Finance Committee )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Stephen R. Davis resigned as Director at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director
  source text: · Stephen R. Davis ( Audit Committee )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm
- Executive change
  Charles S. Grass resigned as Principal Accounting Officer at BELLICUM PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Principal Accounting Officer
  source text: Charles S. Grass resigned as Principal Accounting Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1358403/000153949724000590/0001539497-24-000590-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.